GRFS Grifols SA

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of December  2023

 

Commission File No. 001-35193

 

Grifols, S.A. 

(Translation of registrant’s name into English)

 

Avinguda de la Generalitat, 152-158 

Parc de Negocis Can Sant Joan 

Sant Cugat del Valles 08174 

Barcelona, Spain 

(Address of registrant’s principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F x

Form 40-F ¨

 

 

 

Grifols, S.A.

 

TABLE OF CONTENTS

 

Item			Sequential Page Number
1.	Other Inside Information, dated December 29, 2023	d	3

 

 

Grifols, S.A. Avinguda de la Generalitat 152-158 08174 Sant Cugat del Vallès Barcelona - ESPAÑA Tel. [34] 935 710 500 Fax [34] 935 710 267 www.grifols.com

 

Pursuant to the provisions of article 226 of the Law 6/2023, of March 17, on Securities Markets and Investment Services, Grifols S.A. ("Grifols" or the "Company") hereby informs about the following

 

INSIDE INFORMATION

 

Following the Inside Information communication published today regarding the partial sale of Grifols' stake in Shanghai RAAS Blood Products Co., Ltd. ("SRAAS"), Grifols informs that the capital gain resulting from this transaction, compared to the acquisition price of SRAAS shares, amounts to approximately 250 million euros.

 

In Barcelona, on 29 December 2023

 

Nuria Martín Barnés
Secretary to the Board of Directors

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.

 

	Grifols, S.A.
	By:	/s/ David I. Bell
		Name:	David I. Bell
		Title:	Authorized Signatory

 

Date:  December 29, 2023

 

 

---